Propensity Scores in Pharmacoepidemiology: Beyond the Horizon

Propensity Scores in Pharmacoepidemiology: Beyond the Horizon Curr Epidemiol Rep (2017) 4:271–280 https://doi.org/10.1007/s40471-017-0131-y PHARMACOEPIDEMIOLOGY (S TOH, SECTION EDITOR) 1,2 2 2,3,4 John W. Jackson & Ian Schmid & Elizabeth A. Stuart Published online: 6 November 2017 Springer International Publishing AG, part of Springer Nature 2017 Abstract can optimize sample size given design constraints, weighting Purpose of Review Propensity score methods have become estimators that asymptotically target matched and overlap commonplace in pharmacoepidemiology over the past de- samples, and the incorporation of machine learning to aid in cade. Their adoption has confronted formidable obstacles that covariate selection and model building. arise from pharmacoepidemiology’s reliance on large Summary These recent and encouraging advances should be healthcare databases of considerable heterogeneity and com- further evaluated through simulation and empirical studies, plexity. These include identifying clinically meaningful sam- but nonetheless represent a bright path ahead for the observa- ples, defining treatment comparisons, and measuring covari- tional study of treatment benefits and harms. ates in ways that respect sound epidemiologic study design. Additional complexities involve correctly modeling treatment Keywords Pharmacoepidemiology Comparative . . . decisions in the face of variation in healthcare practice and effectiveness Study design Non-experimental study dealing with missing information and unmeasured confound- Propensity score Causal inference ing. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Epidemiology Reports Springer Journals

Propensity Scores in Pharmacoepidemiology: Beyond the Horizon

Loading next page...
 
/lp/springer_journal/propensity-scores-in-pharmacoepidemiology-beyond-the-horizon-T9cLl076Xp
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Epidemiology
eISSN
2196-2995
D.O.I.
10.1007/s40471-017-0131-y
Publisher site
See Article on Publisher Site

Abstract

Curr Epidemiol Rep (2017) 4:271–280 https://doi.org/10.1007/s40471-017-0131-y PHARMACOEPIDEMIOLOGY (S TOH, SECTION EDITOR) 1,2 2 2,3,4 John W. Jackson & Ian Schmid & Elizabeth A. Stuart Published online: 6 November 2017 Springer International Publishing AG, part of Springer Nature 2017 Abstract can optimize sample size given design constraints, weighting Purpose of Review Propensity score methods have become estimators that asymptotically target matched and overlap commonplace in pharmacoepidemiology over the past de- samples, and the incorporation of machine learning to aid in cade. Their adoption has confronted formidable obstacles that covariate selection and model building. arise from pharmacoepidemiology’s reliance on large Summary These recent and encouraging advances should be healthcare databases of considerable heterogeneity and com- further evaluated through simulation and empirical studies, plexity. These include identifying clinically meaningful sam- but nonetheless represent a bright path ahead for the observa- ples, defining treatment comparisons, and measuring covari- tional study of treatment benefits and harms. ates in ways that respect sound epidemiologic study design. Additional complexities involve correctly modeling treatment Keywords Pharmacoepidemiology Comparative . . . decisions in the face of variation in healthcare practice and effectiveness Study design Non-experimental study dealing with missing information and unmeasured confound- Propensity score Causal inference ing.

Journal

Current Epidemiology ReportsSpringer Journals

Published: Nov 6, 2017

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off